Estrogen replacement raises rat CRP without evidence of complement activation

Area of Science:

• Endocrinology
• Immunology
• Reproductive Biology

Background:

• Estrogen's role in inflammation is controversial, with conflicting data in humans and animal models.
• Previous studies suggested estrogen downregulates C-reactive protein (CRP) in rats, questioning their model suitability.
• Re-evaluation of estrogen's effects on CRP and inflammation in rats is necessary.

Purpose of the Study:

• To re-examine the effects of estrogen withdrawal and replacement on CRP expression in rats.
• To investigate the relationship between estrogen, CRP, and complement activation in a rat model.
• To clarify estrogen's impact on inflammation markers relevant to human physiology.

Main Methods:

• Adult female F-344 rats underwent ovariectomy or sham surgery.
• Ovariectomized rats received varying doses of 17beta-estradiol (E2) or placebo.
• Plasma and hepatic rat C-reactive protein (rCRP), and complement activation markers were measured.

Main Results:

• Ovariectomy significantly reduced plasma rCRP levels compared to sham-operated rats.
• Estrogen replacement therapy (both low and high doses) significantly increased plasma rCRP levels.
• Plasma rCRP correlated positively with hepatic rCRP and serum estradiol levels, but not with complement activation.

Conclusions:

• In mature female rats, ovariectomy decreases and estrogen replacement increases rCRP levels.
• Estrogen's induction of plasma rCRP is mediated, at least partly, by hepatic mechanisms.
• Estrogen's effect on rCRP in rats does not appear to involve or require complement activation.